Heart drug nicorandil tested as new arthritis treatment
NCT ID NCT07516769
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether nicorandil, a drug usually used for heart conditions, can reduce inflammation and improve symptoms in people with active rheumatoid arthritis. 46 participants will take nicorandil tablets for 3 months. Researchers will measure joint disease activity and physical function to see if the drug helps.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nicorandil (oral tablet)
What this could lead to
If it works, this could point toward a new treatment option for rheumatoid arthritis that reduces inflammation and improves daily function.
What could go wrong
This is a small early-phase trial with only 46 people, so results may not apply widely. Nicorandil is not a standard arthritis drug, and its safety and effectiveness are still unproven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHUMATOID ARTHISIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tanta university
RECRUITINGTanta, Gharbia Governorate, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••